Search research articles
Contact Us
Filters
Showing results (891-900 of 1,038) with videos related to
Page
of 104
Sort By:
Blood
|
February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien, Richard R Furman, Steven Coutre, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions
Carol Ann Huff, Ephraim J Fuchs, B Douglas Smith, et al.
Functional & Integrative Genomics
|
May 28, 2008
Genes driving potato tuber initiation and growth: identification based on transcriptional changes using the POCI array
Bjorn Kloosterman, David De Koeyer, Rebecca Griffiths, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2007
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997
Michael R Grever, David M Lucas, Gordon W Dewald, et al.
The International Journal on Drug Policy
|
September 28, 2024
Beyond the 5-year recovery mark: Perspectives of researchers with lived and living experience on public engagement and discourse
Camille C Cioffi, Ryan E Flinn, Emily Pasman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma
G Akpek, R F Ambinder, S Piantadosi, et al.
Blood
|
August 2, 2011
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997
Mitchell R Smith, Donna Neuberg, Ian W Flinn, et al.
British Journal of Haematology
|
November 19, 2016
Real-world clinical experience in the Connect<sup>®</sup> chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres
Anthony Mato, Chadi Nabhan, Neil E Kay, et al.
Ejhaem
|
October 17, 2024
Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy
Nicole Lamanna, Constantine S Tam, Jennifer A Woyach, et al.
Plos One
|
January 17, 2024
Chemobiosis reveals tardigrade tun formation is dependent on reversible cysteine oxidation
Amanda L Smythers, Kara M Joseph, Hayden M O'Dell, et al.
Page
of 104
Search research articles
Search
Showing results (891-900 of 1,038) with videos related to
Sort By:
Page
of 104
Blood
|
February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien, Richard R Furman, Steven Coutre, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions
Carol Ann Huff, Ephraim J Fuchs, B Douglas Smith, et al.
Functional & Integrative Genomics
|
May 28, 2008
Genes driving potato tuber initiation and growth: identification based on transcriptional changes using the POCI array
Bjorn Kloosterman, David De Koeyer, Rebecca Griffiths, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2007
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997
Michael R Grever, David M Lucas, Gordon W Dewald, et al.
The International Journal on Drug Policy
|
September 28, 2024
Beyond the 5-year recovery mark: Perspectives of researchers with lived and living experience on public engagement and discourse
Camille C Cioffi, Ryan E Flinn, Emily Pasman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma
G Akpek, R F Ambinder, S Piantadosi, et al.
Blood
|
August 2, 2011
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997
Mitchell R Smith, Donna Neuberg, Ian W Flinn, et al.
British Journal of Haematology
|
November 19, 2016
Real-world clinical experience in the Connect<sup>®</sup> chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres
Anthony Mato, Chadi Nabhan, Neil E Kay, et al.
Ejhaem
|
October 17, 2024
Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy
Nicole Lamanna, Constantine S Tam, Jennifer A Woyach, et al.
Plos One
|
January 17, 2024
Chemobiosis reveals tardigrade tun formation is dependent on reversible cysteine oxidation
Amanda L Smythers, Kara M Joseph, Hayden M O'Dell, et al.
Page
of 104